apl. Prof. Dr. Udo Gaipl

Medizinische Fakultät Department of Radiation Oncology

Combination of gas plasma and radiotherapy has immunostimulatory potential and additive toxicity in murine melanoma cells in vitro (2020) Pasqual-Melo G, Sagwal SK, Freund E, Gandhirajan RK, Frey B, von Woedtke T, Gaipl U, Bekeschus S Journal article Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials (2020) Zhou JG, Huang L, Jin SH, Xu C, Frey B, Ma H, Gaipl U Journal article, Review article Immune biological rationales for the design of combined radio- and immunotherapies (2020) Hader M, Frey B, Fietkau R, Hecht M, Gaipl U Journal article, Review article Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy (2020) Frey B, Mika J, Jelonek K, Cruz-Garcia L, Roelants C, Testard I, Cherradi N, et al. Journal article Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? (2020) Roedel F, Arenas M, Ott O, Fournier C, Georgakilas AG, Tapio S, Trott KR, Gaipl U Journal article, Review article Erste erfolgversprechende Ergebnisse der Kombination aus Strahlentherapie und Pembrolizumab beim metastasierten nichtkleinzelligen Lungenkarzinom (2020) Hecht M, Gaipl U, Fietkau R Journal article Analysis of the immune status from peripheral whole blood with a single-tube multicolor flow cytometry assay (2020) Donaubauer AJ, Becker I, Rühle PF, Fietkau R, Gaipl U, Frey B Book chapter / Article in edited volumes Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma (2019) Zhou JG, Liang B, Jin SH, Liao HL, Du GB, Cheng L, Ma H, Gaipl U Journal article Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial) (2019) Hecht M, Gostian AO, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Hautmann MG, et al. Conference contribution Radiotherapy-induced changes in the systemic immune and inflammation parameters of head and neck cancer patients (2019) Balazs K, Kis E, Badie C, Bogdandi EN, Candeias S, Garcia LC, Dominczyk I, et al. Journal article